Zimmer Holdings Inc. (ZMH) Reached the 52-Week High of $65.22
The prices of Zimmer Holdings Inc. shares have reached $65.22, which is 0.9% off the 52-week high of $65.8. Zimmer is a global leader in the design, development, manufacturing and market of reconstructive orthopaedic implants and fracture management products. Zimmer Holdings Inc. has a market cap of $10.88 billion; its shares were traded at around $65.22 with a P/E ratio of 12.3 and P/S ratio of 2.4. The dividend yield of Zimmer Holding, Inc. stocks is 1.2%. Zimmer Holdings Inc. had an annual average earnings growth of 16.1% over the past 10 years. GuruFocus rated Zimmer Holdings, Inc. the business predictability rank of 2.5-star.
On July 26, Zimmer Holdings Inc. reported financial results for the quarter ended June 30, 2012. The company reported second quarter net sales of $1,125 million, a decrease of 1.1% reported and an increase of 1.8% constant currency over the second quarter of 2011. Diluted earnings per share for the quarter were $1.22 reported and $1.34 adjusted, an increase of 10.7% adjusted over the prior year period. Net earnings for the second quarter were $214.5 million on a reported basis and $235.6 million on an adjusted basis, an increase of 1.4% adjusted over the prior year period. Operating cash flow for the second quarter was $231.5 million.
Last week, President, Asia Pacific Stephen Hong Liang Ooi sold 25,000 shares of ZMH stock. President Zimmer Reconstructive Jeffery A. McCaulley and Director Larry C. Glasscock sold shares in June. President and CEO David C. Dvorak and Executive Vice President Finance and CFO James T. Crines sold shares in May. Chairman Europe, Africa and Middle East Bruno A. Melzi sold in March.
Chevron Corporation (NYSE:CVX) Reached the 52-Week High of $114
The prices of Chevron Corporation shares have reached $114, which is 0.0% off the 52-week high of $114. Chevron is the fifth-largest integrated energy company in the world. Chevron Corporation has a market cap of $221.26 billion; its shares were traded at around $114 with a P/E ratio of 8.4 and P/S ratio of 0.9. The dividend yield of Chevron Corporation stocks is 3.2%. Chevron Corporation had an annual average earnings growth of 14.7% over the past 10 years. GuruFocus rated Chevron Corporation the business predictability rank of 2.5-star.
On April 27, Chevron Corporation reported earnings of $6.5 billion ($3.27 per share – diluted) for the first quarter 2012, compared with $6.2 billion ($3.09 per share – diluted) in the 2011 first quarter. Sales and other operating revenues in the first quarter 2012 were $59 billion, compared to $58 billion in the year-ago period.
In August, Executive Vice President Michael K. Wirth and Vice Chairman and Executive Vice President George L. Kirkland sold shares of CVX. Vice President and Comptroller Matthew J. Foehr sold 36,000 shares in April.
Visa Inc. (NYSE:V) Reached the 52-Week High of $129.72
The prices of Visa Inc. shares have reached $129.72, which is 1.1% off the 52-week high of $131.15. Visa Inc. operates the world's largest retail electronic payments network and is one of the most recognized global financial services brands. Visa Inc. has a market cap of $104.03 billion; its shares were traded at around $129.72 with a P/E ratio of 21.7 and P/S ratio of 11.3. The dividend yield of Visa Inc. stocks is 0.7%.
On July 25, Visa Inc. announced financial results for the company's fiscal third quarter 2012 ended June 30, 2012. On a GAAP basis, the Company reported a net loss of $1.8 billion. GAAP net operating revenue in the fiscal third quarter of 2012 was $2.6 billion, an increase of 10% over the prior year and driven by strong double-digit growth in service revenues, data processing revenues and international transaction revenues.
Last month, Group President, APCEMEA Elizabeth Buse sold 14,400 shares of V stock. General Counsel Joshua R. Floum, President John Partridge, Chief Enterprise Risk Officer Ellen Richey, and Chairman and CEO Joseph W. Saunders sold shares in July.
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) Reached the 52-Week High of $152.55
The prices of Regeneron Pharmaceuticals Inc. shares have reached $152.55, which is 0.0% off the 52-week high of $152.57. Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for the treatment of serious medical conditions. Regeneron Pharmaceuticals Inc. has a market cap of $14.22 billion; its shares were traded at around $152.55 with and P/S ratio of 31.9.
On July 25, Regeneron Pharmaceuticals Inc. announced financial and operating results for the second quarter of 2012. The company reported total revenues of $304 million in the second quarter and $536 million in the first half of 2012. The company reported non-GAAP net income of $102 million, or $0.90 per diluted share, in the second quarter and $142 million, or $1.28 per diluted share, in the first half of 2012. Non-GAAP net income excludes non-cash share-based compensation expense and non-cash interest expense related to the company's convertible senior notes. The company reported GAAP net income of $77 million, or $0.70 per diluted share, in the second quarter and $88 million, or $0.81 per diluted share, in the first half of 2012.
Last week, Director Charles A. Baker sold 15,000 shares of REGN stock. Senior Vice President Research and Development S. Neil Stahl, Vice President Controller and Assistant Treasurer Douglas S. McCorkle, Vice President Regulatory Development and William Roberts, Director George L. Sing, and Senior Vice President Finance and Administrative CFO Treasurer Murray A. Goldberg sold shares in August. President & CEO Leonard S Schleifer sold shares in May.
Discover Financial Services (NYSE:DFS) Reached the 52-Week High of $38.47
The prices of Discover Financial Services shares have reached $38.47, which is 1.2% off the 52-week high of $38.92. Discover Financial Services operates the Discover Card with more than 50 million cardmembers, the Discover Network with millions of merchant and cash access locations, and the Goldfish credit card business in the UK. Discover Financial Services has a market cap of $19.94 billion; its shares were traded at around $38.47 with a P/E ratio of 9 and P/S ratio of 2.3. The dividend yield of Discover Financial Services stocks is 1%. Discover Financial Services had an annual average earnings growth of 20.2% over the past 5 years.
On June 19, Discover Financial Services reported net income of $537 million or $1.00 per diluted share for the second quarter of 2012, as compared to $600 million or $1.09 per share for the second quarter of 2011. Strong year-over-year revenue growth was offset by lower reserve releases. The company’s return on equity was 24%.
In July, Director Michael H. Moskow and Executive Vice President Carlos Minetti sold shares of DFS stock. Executive Vice President, Chief Credit Risk Officer James V. Panzarino sold 40,000 shares in June. Executive Vice President Diane E. Offereins sold 98,373 shares in April and Executive Vice President Harit Talwar sold 153,501 shares in March.